Cargando…
Rising JCV-Ab index during natalizumab therapy for MS: Inauspicious for a highly efficacious drug
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4733148/ https://www.ncbi.nlm.nih.gov/pubmed/26848488 http://dx.doi.org/10.1212/NXI.0000000000000199 |
| _version_ | 1782412801327759360 |
|---|---|
| author | Javed, Adil Reder, Anthony T. |
| author_facet | Javed, Adil Reder, Anthony T. |
| author_sort | Javed, Adil |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4733148 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2016 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-47331482016-02-04 Rising JCV-Ab index during natalizumab therapy for MS: Inauspicious for a highly efficacious drug Javed, Adil Reder, Anthony T. Neurol Neuroimmunol Neuroinflamm Editorial Lippincott Williams & Wilkins 2016-01-27 /pmc/articles/PMC4733148/ /pubmed/26848488 http://dx.doi.org/10.1212/NXI.0000000000000199 Text en © 2016 American Academy of Neurology This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially. |
| spellingShingle | Editorial Javed, Adil Reder, Anthony T. Rising JCV-Ab index during natalizumab therapy for MS: Inauspicious for a highly efficacious drug |
| title | Rising JCV-Ab index during natalizumab therapy for MS: Inauspicious for a highly efficacious drug |
| title_full | Rising JCV-Ab index during natalizumab therapy for MS: Inauspicious for a highly efficacious drug |
| title_fullStr | Rising JCV-Ab index during natalizumab therapy for MS: Inauspicious for a highly efficacious drug |
| title_full_unstemmed | Rising JCV-Ab index during natalizumab therapy for MS: Inauspicious for a highly efficacious drug |
| title_short | Rising JCV-Ab index during natalizumab therapy for MS: Inauspicious for a highly efficacious drug |
| title_sort | rising jcv-ab index during natalizumab therapy for ms: inauspicious for a highly efficacious drug |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4733148/ https://www.ncbi.nlm.nih.gov/pubmed/26848488 http://dx.doi.org/10.1212/NXI.0000000000000199 |
| work_keys_str_mv | AT javedadil risingjcvabindexduringnatalizumabtherapyformsinauspiciousforahighlyefficaciousdrug AT rederanthonyt risingjcvabindexduringnatalizumabtherapyformsinauspiciousforahighlyefficaciousdrug |